Celcuity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.

About CELC

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. 

CEO
Brian F. Sullivan
CEOBrian F. Sullivan
Employees
155
Employees155
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
2012
Founded2012
Employees
155
Employees155

CELC Key Statistics

Market cap
6.67B
Market cap6.67B
Price-Earnings ratio
-35.32
Price-Earnings ratio-35.32
Dividend yield
Dividend yield
Average volume
1.58M
Average volume1.58M
High today
$139.63
High today$139.63
Low today
$127.04
Low today$127.04
Open price
$130.20
Open price$130.20
Volume
1.48M
Volume1.48M
52 Week high
$151.02
52 Week high$151.02
52 Week low
$10.26
52 Week low$10.26

Stock Snapshot

Celcuity(CELC) stock is priced at $136.50, giving the company a market capitalization of 6.67B. It carries a P/E multiple of -35.32.

On 2026-05-17, Celcuity(CELC) stock traded between a low of $127.04 and a high of $139.63. Shares are currently priced at $136.50, which is +7.4% above the low and -2.2% below the high.

The Celcuity(CELC)'s current trading volume is 1.48M, compared to an average daily volume of 1.58M.

During the past year, Celcuity(CELC) stock moved between $10.26 at its lowest and $151.02 at its peak.

During the past year, Celcuity(CELC) stock moved between $10.26 at its lowest and $151.02 at its peak.

CELC News

Simply Wall St 14h
Why Celcuity Is Up 5.1% After VIKTORIA-1 Success And Pipeline Expansion - And What's Next

Celcuity Inc. has reported that its Phase 3 VIKTORIA-1 trial of gedatolisib in HR-positive, HER2-negative advanced breast cancer met its primary progression-fre...

Why Celcuity Is Up 5.1% After VIKTORIA-1 Success And Pipeline Expansion - And What's Next
TipRanks 2d
Celcuity’s Earnings Call: Strong Data, Rising Cash Burn

Celcuity Inc. ((CELC)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and power...

Benzinga 2d
Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst

The company also disclosed progress on a subcutaneous formulation of gedatolisib aimed at supporting long-term treatment use. Trial To Include Endocrine-Sensiti...

Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

More CELC News

TipRanks 3d
Celcuity price target raised to $175 from $150 at Stifel

Stifel raised the firm’s price target on Celcuity (CELC) to $175 from $150 and keeps a Buy rating on the shares. Unlock hedge fund-level data and powerful inve...

Nasdaq 3d
Celcuity Q1 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Celcuity Q1 2026 Earnings Transcript
TipRanks 3d
Celcuity reports Q1 adjusted EPS (86c) vs. (81c) last year

Net cash used in operating activities for the first quarter of 2026 was $55.1M, compared to $35.9M for the prior year period. “With positive results in both coh...

People also own

Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.